Literature DB >> 19438740

Acupuncture for treating acute attacks of migraine: a randomized controlled trial.

Ying Li1, Fanrong Liang, Xuguang Yang, Xiaoping Tian, Jie Yan, Guojie Sun, Xiaorong Chang, Yong Tang, Tingting Ma, Li Zhou, Lei Lan, Wen Yao, Ran Zou.   

Abstract

OBJECTIVE: To discuss the results of a multicenter randomized controlled trial of the efficacy of verum acupuncture in treating acute migraine attacks.
BACKGROUND: Acupuncture has been used in China for centuries to treat migraine headache. Convincing evidence of its efficacy in alleviating pain, however, has been inadequate to date.
METHODS: A total of 218 patients with migraine were recruited for the study; 180 met the inclusion criteria; 175 completed the callback process and were randomized into 3 groups. One group received verum acupuncture while subjects in the other 2 groups were treated with sham acupuncture. Each patient received 1 session of treatment and was observed over a period of 24 hours. The main outcome measure was the differences in visual analog scale (VAS) scores before treatment and 0.5, 1, 2, and 4 hours after treatment.
RESULTS: Significant decreases in VAS scores from baseline were observed in the fourth hour after treatment when VAS was measured in the patients who received either verum acupuncture or sham acupunctures (P < .05). The VAS scores in the fourth hour after treatment decreased by a median of 1.0 cm, 0.5 cm, and 0.1 cm in the verum acupuncture group, sham acupuncture group 1, and sham acupuncture group 2, respectively. Similarly, there was a significant difference in the change in VAS scores from baseline in the second hour after treatment among the 3 groups (P = .006). Moreover, at the second hour after treatment, only patients treated with verum acupuncture showed significant decreases in VAS scores from baseline by a median of 0.7 cm (P < .001). Significant differences were observed in pain relief, relapse, or aggravation within 24 hours after treatment as well as in the general evaluations among the 3 groups (P < .05). Most patients in the acupuncture group experienced complete pain relief (40.7%) and did not experience recurrence or intensification of pain (79.6%).
CONCLUSION: Verum acupuncture treatment is more effective than sham acupuncture based on either Chinese or Western nonacupoints in reducing the discomfort of acute migraine. Verum acupuncture is also clearly effective in relieving pain and preventing migraine relapse or aggravation. These findings support the contention that there are specific physiological effects that distinguish genuine acupoints from nonacupoints.

Entities:  

Mesh:

Year:  2009        PMID: 19438740     DOI: 10.1111/j.1526-4610.2009.01424.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  35 in total

1.  Acupuncture for migraine prophylaxis: a randomized controlled trial.

Authors:  Ying Li; Hui Zheng; Claudia M Witt; Stephanie Roll; Shu-guang Yu; Jie Yan; Guo-jie Sun; Ling Zhao; Wen-jing Huang; Xiao-rong Chang; Hong-xing Zhang; De-jun Wang; Lei Lan; Ran Zou; Fan-rong Liang
Journal:  CMAJ       Date:  2012-01-09       Impact factor: 8.262

2.  Acupuncture for symptom management in patients with hyper-IgE (Job's) syndrome.

Authors:  Adeline X Y Ge; Mary E Ryan; Steven M Holland; Alexandra F Freeman; Victoria L Anderson; Fei Wang; Jim W Fleshman
Journal:  J Altern Complement Med       Date:  2011-01-05       Impact factor: 2.579

3.  Issues of design and statistical analysis in controlled clinical acupuncture trials: an analysis of English-language reports from Western journals.

Authors:  Ping Shuai; Xiao-Hua Zhou; Lixing Lao; Xiaosong Li
Journal:  Stat Med       Date:  2011-02-22       Impact factor: 2.373

4.  De-qi, not psychological factors, determines the therapeutic efficacy of acupuncture treatment for primary dysmenorrhea.

Authors:  Jin Xiong; Fang Liu; Ming-Min Zhang; Wei Wang; Guang-Ying Huang
Journal:  Chin J Integr Med       Date:  2011-10-12       Impact factor: 1.978

5.  Migraine: is acupuncture clinically viable for treating acute migraine?

Authors:  Hans-Christoph Diener
Journal:  Nat Rev Neurol       Date:  2009-09       Impact factor: 42.937

6.  Utilization of Acupuncture Services in the Emergency Department Setting: A Quality Improvement Study.

Authors:  John R Burns; Jessica J F Kram; Vashir Xiong; Jeanne M Stark Casadont; Tiffany A Mullen; Nancy Conway; Dennis J Baumgardner
Journal:  J Patient Cent Res Rev       Date:  2019-04-29

7.  Acupuncture for patients with mild hypertension: A randomized controlled trial.

Authors:  Hui Zheng; Juan Li; Ying Li; Ling Zhao; Xi Wu; Jie Chen; Xiang Li; Yin-Lan Huang; Xiao-Rong Chang; Mi Liu; Jin Cui; Rui-Hui Wang; Xu Du; Jing Shi; Tai-Pin Guo; Fan-Rong Liang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-02-08       Impact factor: 3.738

8.  Improved quality monitoring of multi-center acupuncture clinical trials in China.

Authors:  Ling Zhao; Fan-rong Liang; Ying Li; Fu-wen Zhang; Hui Zheng; Xi Wu
Journal:  Trials       Date:  2009-12-27       Impact factor: 2.279

9.  Acute Treatments for Episodic Migraine in Adults: A Systematic Review and Meta-analysis.

Authors:  Juliana H VanderPluym; Rashmi B Halker Singh; Meritxell Urtecho; Allison S Morrow; Tarek Nayfeh; Victor D Torres Roldan; Magdoleen H Farah; Bashar Hasan; Samer Saadi; Sahrish Shah; Rami Abd-Rabu; Lubna Daraz; Larry J Prokop; Mohammad Hassan Murad; Zhen Wang
Journal:  JAMA       Date:  2021-06-15       Impact factor: 56.272

10.  Revealing the Neural Mechanism Underlying the Effects of Acupuncture on Migraine: A Systematic Review.

Authors:  Lu Liu; Tian Tian; Xiang Li; Yanan Wang; Tao Xu; Xixiu Ni; Xiao Li; Zhenxi He; Shan Gao; Mingsheng Sun; Fanrong Liang; Ling Zhao
Journal:  Front Neurosci       Date:  2021-05-20       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.